Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Current genetics 37 (2000), S. 119-124 
    ISSN: 1432-0983
    Keywords: Key words Ribosomal protein gene crp-7 ; RFLP mapping ; Super induction ; Neurospora crassa
    Source: Springer Online Journal Archives 1860-2000
    Topics: Biology
    Notes: Abstract We have isolated and characterized a Neurospora crassa cytoplasmic ribosomal protein gene, named crp-7, which is found upstream of the photolyase gene. The deduced amino-acid sequence of this gene is highly homologous to the YS25 ribosomal protein of Saccharomyces cerevisiae. The crp-7 ORF consists of two exons which are separated by a short intron. The deduced polypeptide contains 87 amino acid residues and has a calculated molecular weight of 9.7 kDa. RFLP mapping showed that the crp-7 gene is located on the right arm of linkage group I. Southern blot hybridization analyses indicated that there is only one copy of the crp-7 gene in the N. crassa genome. Transcriptional elements, the Dde box, the Taq box and the CG element, that have been identified in other N. crassa ribosomal protein genes are observed in the promoter region of the crp-7 gene. The crp-7 mRNA levels were low in conidia and highest in young mycelia during vegetative growth. The mRNA levels of four r-protein genes, including the crp-7 gene, as well as the tef-1 gene encoding translational elongation factor 1α, were raised following the treatment of mycelia with a low concentration of cycloheximide. This indicates that the expression of r-protein genes is under the control of so-called super-induction.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1569-8041
    Keywords: Interleukin (IL)-10 mRNA ; IL-10 receptor mRNA ; non-small-cell lung cancer (NSCLC) ; prognosis
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Background:The type 2 cytokine interleukin (IL)-10 has beenreported to inhibit the antitumour activity of the regional immunity againstvarious neoplasms. Certain lung cancers produce IL-10, but the clinicalsignificance of IL-10 expression is not well understood. Patients and methods:We examined IL-10 and IL-10 receptor(IL-10R) mRNA expression in 82 non-small-cell lung cancers (NSCLC) by reversetranscription-polymerase chain reaction (RT–PCR) assay.Immunohistochemistry (IHC) and enzyme immunoassay (EIA) were applied toevaluate the cellular localisation and the serum levels of IL-10. Results:RT–PCR assay revealed IL-10 mRNA expression in 68(83%) of 82 NSCLC surgical specimens (40 of 50 adenocarcinomas, 22 of26 squamous cell carcinomas, 5 of 5 large-cell carcinomas, 1 of 1adenosquamous-cell carcinoma). RT–PCR assay also revealed IL-10R mRNAexpression in 79 cases of NSCLC (96.1%). IL-10 expression was confirmedwithin tumour cells by IHC. EIA showed no significant serum IL-10 elevationin the 12 NSCLC positive for IL-10 mRNA expression (0–2.99 pg/ml). TheNSCLC patients with IL-10 production showed significantly poorer prognosisthan those without IL-10 production (P 〈 0.05, Kaplan–Meier,log-rank test). Conclusions:These results suggested that the cytoplasmic IL-10correlated to clinical prognosis, and that IL-10 expression is a prognosticfactor for NSCLC.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...